Instruct: Identify the main category of Biorxiv papers based on the titles and abstracts
Query: Early therapy with remdesivir and antibody combinations improves COVID-19 disease in mice Improving the standard of clinical care for individuals infected with SARS-CoV-2 variants is a global health priority. Small molecule antivirals like remdesivir (RDV) and biologics such as human monoclonal antibodies (mAb) have demonstrated therapeutic efficacy against SARS-CoV-2, the causative agent of COVID-19. However, it is not known if combination RDV/mAb will improve outcomes over single agent therapies or whether antibody therapies will remain efficacious against variants. In kinetic studies in a mouse-adapted model of ancestral SARS-CoV-2 pathogenesis, we show that a combination of two mAbs in clinical trials, C144 and C135, have potent antiviral effects against even when initiated 48 hours after infection. The same antibody combination was also effective in prevention and therapy against the B.1.351 variant of concern (VOC). Combining RDV and antibodies provided a modest improvement in outcomes compared to single agents. These data support the continued use of RDV to treat SARS-CoV-2 infections and support the continued clinical development of the C144 and C135 antibody combination to treat patients infected with SARS-CoV-2 variants.
3
The categories of this paper are: evolutionary
13
The categories of this paper are: animal
8
The categories of this paper are: genomics
10
The categories of this paper are: and
26
The categories of this paper are: biochemistry
14
The categories of this paper are: biophysics
18
The categories of this paper are: systems
25
The categories of this paper are: bioengineering
11
The categories of this paper are: cognition
31
The categories of this paper are: paleontology
21
The categories of this paper are: toxicology
19
The categories of this paper are: epidemiology
23
The categories of this paper are: immunology
28
The categories of this paper are: communication
29
The categories of this paper are: education
24
The categories of this paper are: cancer